Navigation Links
Haemonetics Reports 2nd Quarter Fiscal 2014 Revenue Up 8%; Adjusted Operating Margin Up 260 Basis Points; and $0.66 Adjusted EPS Up 24%
Date:10/28/2013

ma disposables.

Adjusted operating expenses were $74.4 million in the quarter, up $2.5 million or 4%.  Operating expense increases included a full quarter of the whole blood business. Additionally, planned investments were made in emerging markets and R&D to continue to drive anticipated revenue growth.  Ongoing spending discipline and variable compensation reductions offset investments, leaving operating expenses at 31.5% of revenue. Increased R&D spending planned for the second half of fiscal 2014 is vital to the introduction of planned new products and, accordingly, operating expenses are expected to increase in the back half of the fiscal year.

Adjusted operating income was $49.0 million in the second quarter, up $9.3 million or 23%, and included a full quarter's whole blood profits.  Adjusted operating margin was 20.8%, up 260 basis points.  Productivity gains and operating expense management resulted in improved operating margin.  However, the Company expects to increase spending for key research and development projects in the second half of fiscal 2014, resulting in an adjusted operating margin of approximately 19% for the full fiscal year.

The income tax rate was 26.2% compared with 27.6% in the prior year second quarter, reflecting the ongoing implementation of a global tax strategy.  Interest expense on loans was $2.5 million in the quarter.

VALUE CREATION & CAPTURE ACTIVITIES Haemonetics indicated that the integration of its whole blood business, acquired in August 2012, was substantially completed in the second quarter, ahead of its original schedule.  Plans to pursue identified Value Creation & Capture ("VCC") opportunities, including transformation of the Company's manufacturing footprint, are progressing according to schedule and expected to deliver benefits previously indicated.  Such benefits include substantial savings, beginning in fiscal 2015 with $21 million, a
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard
2. Haemonetics Reports 1st Quarter Fiscal 2014 Revenue Up 24%; Adjusted EPS of $0.46 Up 46%; Adjusted Operating Margin Improvement of 270 Basis Points; and Significant Progress on Planned Manufacturing Transformation
3. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
4. Haemonetics Announces Next Steps in Manufacturing Transformation
5. Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference
6. Haemonetics Completes Hemerus Medical, LLC Acquisition
7. Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidanc
8. Haemonetics Sets Date for Investor/Analyst Meeting
9. Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
10. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
11. Haemonetics Completes Acquisition of Palls Transfusion Medicine Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Calif., July 29, 2015  STAAR Surgical Company (NASDAQ: ... lenses and delivery systems for the eye today reported financial ... Second Quarter Overview , Net Sales of ... , Unfavorable Currency Impact of $2.1 Million from the Weakening ... EMEA and 13% in China , APAC Sales Down ...
(Date:7/29/2015)... DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... June 30, 2015. For the second quarter of 2015, the Company ... share, compared to a net loss of $13.4 million, or $0.18 ... six months ended June 30, 2015, the Company reported a net ... to net loss of $25.2 million, or $0.35 loss per share, ...
(Date:7/29/2015)... 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... up to $21.5 million through two financing agreements. The ... ) ("Hercules"), for a term loan of up to ... Growth Fund ("Discover"), for the sale to Discover of ... Stock") for up to $12 million in gross proceeds ...
Breaking Medicine Technology:STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5
... 22, 2010 Pfizer Inc (NYSE: PFE ... to both the United States Food and Drug Administration ... the use of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine ... and older for the prevention of pneumococcal disease caused ...
... Dec. 22, 2010 Haemonetics Corporation (NYSE: ... Chief Executive Officer, will present at the J.P. Morgan ... 2011 at 1:30 pm Pacific time.  The ... at http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink?ticker=HAE .  The webcast ...
Cached Medicine Technology:Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 2Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 3Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 4Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 5
(Date:7/30/2015)... ... July 30, 2015 , ... ... amount of research grants in its history of funding brain aneurysm research. ... have dedicated their life’s work toward scientific research directed at early detection, improved ...
(Date:7/30/2015)... ... ... PeopleKeys, a company with over 30 years of experience in behavioral analysis, ... the newest installment in their popular DISC for the Real World series, will air ... webinar is intended for people interested in training others to use DISC behavioral analysis ...
(Date:7/29/2015)... ... ... Drs. Hamstead are very excited to announce the expansion of AlignLife ... the clinic; massage therapy works very well alongside chiropractic care to restore balance to ... of Simpsonville to work alongside the doctors. Many people can benefit from massage therapy ...
(Date:7/29/2015)... ... 2015 , ... According to an article published July 23 by the Daily Mail, ... what a person needs to do in terms of physical activity and caloric intake to ... estimates as to the number of calories a person needs to consume to maintain or ...
(Date:7/29/2015)... ... July 29, 2015 , ... Conventional theories used by ... goods and services may be able to unlock mysteries about the behavior of microbial ... , Boston University, and Columbia University. , The findings, published July 29 in the ...
Breaking Medicine News(10 mins):Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 2Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 3Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 4Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:AlignLife of Simpsonville Hires Massage Therapist 2Health News:New NIH Body Weight Planner Illustrates the Need for Reduced Caloric Intake When Trying to Lose Weight, Says Beverly Hills Physicians 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3
... and Leigh NHS Foundation Trust (WWL), a major acute facility serving ... north west of England, was recently awarded NHS Foundation Trust status. ... ... -- Orion Health http://www.orionhealth.com , a leading provider of clinical ...
... Megan,s Purple Day USA by turning DrGreene.com purple for the day and ... ... and author Dr. Alan Greene is known for wearing green socks 365 ... of purple., , , , ,March 26 is Purple Day USA ...
... WASHINGTON, March 24 Surgical groups, led by the ... health care stakeholders, today announced the formation of Operation ... to bring into focus the urgent issues facing access ... With nearly 400 surgeons from around the country meeting ...
... March 24 Meningitis Angels, a Texas-based, ... is excited to support the first annual ... 2009. The observance is being coordinated and ... (CoMO), an Australia-based global advocacy group comprised ...
... and analyses from a long-running study of cancer survival in ... of cancer rather than just surviving for at least ... special issue of the European Journal of Cancer ... the first time, an estimate of the proportions of patients ...
... 23 Did you know one in six men ... to this report from Men,s Health Network at: ... over 186,000 men will be diagnosed with prostate cancer ... important to realize that prostate cancer does not affect ...
Cached Medicine News:Health News:Orion Health Congratulates Wrightington, Wigan and Leigh NHS Foundation Trust on Achieving Community-based Governance 2Health News:Orion Health Congratulates Wrightington, Wigan and Leigh NHS Foundation Trust on Achieving Community-based Governance 3Health News:Orion Health Congratulates Wrightington, Wigan and Leigh NHS Foundation Trust on Achieving Community-based Governance 4Health News:Renowned Pediatrician Joins Fight for Epilepsy Awareness for Purple Day 2Health News:Renowned Pediatrician Joins Fight for Epilepsy Awareness for Purple Day 3Health News:Surgical Groups Form 'Operation Patient Access: Quality Surgical Care for All' to Call Attention to Escalating Workforce Shortage 2Health News:Surgical Groups Form 'Operation Patient Access: Quality Surgical Care for All' to Call Attention to Escalating Workforce Shortage 3Health News:Surgical Groups Form 'Operation Patient Access: Quality Surgical Care for All' to Call Attention to Escalating Workforce Shortage 4Health News:Meningitis Angels to Support First Annual World Meningitis Day 2Health News:New data on cancer survival in Europe show more patients are cured 2Health News:New data on cancer survival in Europe show more patients are cured 3Health News:New data on cancer survival in Europe show more patients are cured 4Health News:New data on cancer survival in Europe show more patients are cured 5
... provides both pressure and flow calculations ... in a combined screen format utilizing ... Volcano's unique Doppler FloWire. Physiologic measurements ... to assess ambiguous or intermediate lesions, ...
... D-Series Plus from BERCHTOLD offers you a complete ... returning 98% of the bulb's original illumination to ... radiant energy., ,The light field is clear and ... and a neutral white color temperature of 4500 ...
... Convert any EMG/EP or EEG ... with these easy-to-install adapters. Available in ... Department at 1-800-245-3001 or 509-735-6481 for ... other manufacturers equipment. Sold individually. Adhesive ...
... elastic fabric, these head cap systems are ... begin testing. Each Electro-Cap System features pure ... 10-20 System. When you place your order, ... with your head cap system and whether ...
Medicine Products: